Cerebronal® food supplement improve status of markers ofdementia and regeneration
DOI:
https://doi.org/10.31989/dsn.v4i9.1689Abstract
Background: Brain diseases, including neurodegenerative disorders such as Alzheimer's disease, represent a significant global health burden with rising prevalence due to aging populations. Cerebronal® (Medicinalis) is a dietary supplement formulated with a proprietary blend of plant extracts, acetyl L-carnitine, nucleotides, vitamins, and antioxidants designed to support brain health and cognitive function.
Objective: This study evaluated the effects of Cerebronal® supplementation during three to six months
implementation on biomarkers associated with neurodegeneration and brain regeneration in 54 outpatients
experiencing memory problems. Hair follicle cells were collected and directly reprogrammed into neurons for analysis of key proteins including total Tau, phosphorylated Tau181, beta-amyloid 42, neurogranin, and VEGF using ELISA assays (Check My Brain®, Omnion Research International).
Results: While total Tau and beta-amyloid levels showed no significant changes, a subgroup of patients with elevated Tau181/total Tau ratios exhibited a significant reduction after supplementation. Additionally, patients with initially low levels of neurogranin and VEGF demonstrated significant increases, indicating potential improvements in synaptic function and neurovascular support.
Novelty: These novel findings suggest that Cerebronal® may beneficially modulate specific molecular markers linked to neurodegeneration and brain repair in vulnerable individuals. In addition, the study highlights the utility of hair follicle-derived neuronal cultures as a minimally invasive tool for monitoring biomarker changes.
Conclusion: Although more research with higher number of participants will be needed, overall, Cerebronal® shows promise as an adjunctive intervention for cognitive health, with quantitatively proven benefits.
Keywords: neurodegenerative disorders, biomarkers, food supplements, Tau, Tau181, beta amyloid, neurogranin, VEGF
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dietary Supplements and Nutraceuticals - Online ISSN: 2771-5604
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.